Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features
Overview
Authors
Affiliations
It has been suggested that oxidative stress may play a role in the pathogenesis of Autism Spectrum Disorders (ASD), but the literature reports somewhat contradictory results. To further investigate the issue, we evaluated a high number of peripheral oxidative stress parameters, and some related issues such as erythrocyte membrane functional features and lipid composition. Twenty-one autistic children (Au) aged 5 to 12 years, were gender and age-matched with 20 typically developing children (TD). Erythrocyte thiobarbituric acid reactive substances, urinary isoprostane and hexanoyl-lysine adduct levels were elevated in Au, thus confirming the occurrence of an imbalance of the redox status of Au, whilst other oxidative stress markers or associated parameters (urinary 8-oxo-dG, plasma radical absorbance capacity and carbonyl groups, erythrocyte superoxide dismutase and catalase activities) were unchanged. A very significant reduction of Na(+)/K(+)-ATPase activity (-66%, p<0.0001), a reduction of erythrocyte membrane fluidity and alteration in erythrocyte fatty acid membrane profile (increase in monounsaturated fatty acids, decrease in EPA and DHA-ω3 with a consequent increase in ω6/ω3 ratio) were found in Au compared to TD, without change in membrane sialic acid content. Some Au clinical features appear to be correlated with these findings; in particular, hyperactivity score appears to be related with some parameters of the lipidomic profile and membrane fluidity. Oxidative stress and erythrocyte membrane alterations may play a role in the pathogenesis of ASD and prompt the development of palliative therapeutic protocols. Moreover, the marked decrease in NKA could be potentially utilized as a peripheral biomarker of ASD.
The Role of Oxidative Stress in Autism Spectrum Disorder Pathophysiology, Diagnosis and Treatment.
Kuzniar-Palka A Biomedicines. 2025; 13(2).
PMID: 40002801 PMC: 11852718. DOI: 10.3390/biomedicines13020388.
Puljko B, Stracak M, Kalanj-Bognar S, Todoric Laidlaw I, Mlinac-Jerkovic K Int J Mol Sci. 2025; 26(3).
PMID: 39941090 PMC: 11818915. DOI: 10.3390/ijms26031322.
Jasenovec T, Radosinska D, Belica I, Raskova B, Puzserova A, Vrbjar N Biomedicines. 2024; 12(11).
PMID: 39595183 PMC: 11591841. DOI: 10.3390/biomedicines12112619.
Frontal and occipital brain glutathione levels are unchanged in autistic adults.
Pereira A, Leonard A, Velthuis H, Wong N, Ponteduro F, Dimitrov M PLoS One. 2024; 19(8):e0308792.
PMID: 39146282 PMC: 11326623. DOI: 10.1371/journal.pone.0308792.
Signorini C, Pannuzzo G, Graziano A, Moretti E, Collodel G, Cardile V Int J Mol Sci. 2024; 25(13).
PMID: 39000257 PMC: 11241235. DOI: 10.3390/ijms25137149.